Dr. Hou's research has focused on the development of radio-labelled chemical entities for the potential use in the imaging of various diseases using Positron Emission Tomography (PET), and the discovery of drug molecules targeting disease-relevant targets through computational molecular design, organic synthesis and molecular biology. The longer-term goal of his research is contributing to the integration of PET imaging into drug discovery.
